A SYNOPSIS

ON

"To Study OF The Marketing Strategies

of Pharmaceutical sector”
At
Nova global Medicare pvt ltd

Submitted by,
Swamiraj Nimbalkar
MBA-II (Marketing)
  Introduction

Marketing strategy is a long-term, forward-looking approach to planning with the

fundamental goal of achieving a sustainable competitive advantage. The marketing strategy
lays out target markets and the value proposition that will be offered based on an analysis of
the best market opportunities.

The Indian pharmaceutical industry came into existence in 1901, when Bengal Chemical &
Pharmaceutical Company started its maiden operation in Calcutta. The pharmaceutical
industry is the world’s largest industry. The industry has seen major changes in the recent
years that place new demands on payers, providers and manufacturers. Indian Pharmaceutical
Industry is poised for high consistent growth over the next few years, driven by a multitude
of factors. The pharmaceutical industry is a knowledge driven industry and is heavily
dependent on Research and Development for new products and growth.

Many pharmaceutical companies have successfully deployed a plethora of strategies to target

the various customer types, recent business and customer trends are creating new challenges
and opportunities for increasing profitability. In the pharmaceutical and healthcare industries,
a complex web of decision-makers determines the nature of the transaction (prescription) for
which direct customer (doctor) of Pharma industry is responsible. Essentially, the end-user
(patient) consumes a product and pays the cost.
  Objectives:

 PRIMARY OBJECTIVE:
The pharmaceutical industry discovers, develops, produces, and markets drugs or
pharmaceutical drugs for use as medications to be administered to patients, with the aim to
cure them, vaccinate them, or alleviate the symptoms.

 SECONDARY OBJECTIVE:

 Identify viable technology drivers through a comprehensive look at various platform

technologies for the Indian pharmaceutical industry.

 Obtain a complete understanding of the Indian pharmaceutical industry practices from

its basic principles to its applications.

 Discover feasible market opportunities via an identification of high-growth

applications in different areas of the Indian pharmaceutical industry.

 Focus on global industry development through an in-depth analysis of the major

world markets for pharmaceutical manufacturing, including forecasts for growth.

 Establish the essentials of the Indian pharmaceutical market including definitions,

processes and trends.
  Scope of the study

Over the years pharmacy has grown in the form of pharmaceuticals sciences through research
and development processes. It is related to product as well as to services. The various drugs
discovered and developed are its products and the healthcare it provides comes under the
category of services.

The Indian Biotechnology Industry which is also a major component in the pharmaceutical
industry and comprises of biopharmaceuticals, bio-agriculture, bio-services, bio-industry and
bioinformatics is expected to reach US $100 Billion by 2025, growing at an average rate of
30 percent per year. With a growing need & requirements of the industry, there are a huge
opportunities coming from the pharma industry.

 Research Methodology

A Research Methodology defines the purpose of the research, how its proceeds, how to major
progress and what constitute success with respect to the objectives determined for carrying
out the research study. The Appropriate research design formulated is detailed below.

Research Methodology is the process of systematic investigation of any management

problem it deals with research design, data collection method, sampling plan, sampling
method.

PRIMARY DATA
Primary data is known as data collected for the first time through field Survey. Such data are
collected with specific set objectives. Primary data Always reveals the cross section picture
of anything studied. This is Needed in research to study the effect or impact any policy.

SECONDARY DATA
Secondary data was collected through

Articles

Reports

Journals

Magazines

Newspaper

Internet

 Limitations Of the study

 Investment in research and development is extremely risky.

 Pharmaceutical corporations are highly regulated.

 The cost of product development is extremely high.

 Manufacturing plants are expensive, require regulatory approval from every agency
from every country in which you will sell the drug.

 Quality control is a critical cost point. In general, they are all powerful in blocking
release of products. They set expiration dates.

 There are high ethical standards, which often cause delays in launch of products.
  Industry Profile

Nova Global Medicare Private Limited is a Private incorporated on 02 March 2015. It is

classified as Non-govt company and is registered at Registrar of Companies, Pune. Its
authorized share capital is Rs. 100,000 and its paid up capital is Rs. 100,000. It is inolved in
Manufacture of other chemical products

Nova Global Medicare Private Limited's Annual General Meeting (AGM) was last held on 29
September 2018 and as per records from Ministry of Corporate Affairs (MCA), its balance
sheet was last filed on 31 March 2018.

Directors of Nova Global Medicare Private Limited are Manish Vijaykumar Shetty, Anamika
Girish Deshmukh, Ashish Vijaykumar Shetty, Chandana Manish Shetty.